Risk factors for surgically treated benign prostatic hyperplasia in Western Australia

Public Health

Volumn 121, Issue 10, 2007, Pages 781-789

  Fritschi, Lin ^a   Tabrizi, Jafar ^b   Leavy, Justine ^c   Ambrosini, Gina ^c   Timperio, Anna ^d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d DEAKIN UNIVERSITY   (Australia)

Author keywords

Alcohol; Benign prostatic hyperplasia; Case control study; Physical activity; Risk factors

Indexed keywords

HORMONE;

CANCER; DEMOGRAPHIC SURVEY; LIFESTYLE; MEDICAL GEOGRAPHY; REGRESSION ANALYSIS; RISK FACTOR;

ADULT; AGED; ALCOHOL CONSUMPTION; ALOPECIA; ARMY; ARTICLE; AUSTRALIA; BIRTHPLACE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DRINKING BEHAVIOR; FAMILY HISTORY; HUMAN; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; OCCUPATION; PHYSICAL ACTIVITY; POPULATION BASED CASE CONTROL STUDY; PRIVATE HOSPITAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATE SURGERY; PUBLIC HOSPITAL; RISK FACTOR; SMOKING; STATISTICAL SIGNIFICANCE; VASECTOMY;

ADULT; AGED; CASE-CONTROL STUDIES; HORMONES; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; QUESTIONNAIRES; RISK FACTORS; WESTERN AUSTRALIA;

AUSTRALASIA; AUSTRALIA; WESTERN AUSTRALIA;

EID: 34548034447     PISSN: 00333506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.puhe.2007.01.011     Document Type: Article

References (35)

1. McVary K. Management of benign prostatic hypertrophy (2004), Humana Press, Totowa, NJ
2. Pinnock C., and Marshall V.R. Troublesome lower urinary tract symptoms in the community: a prevalence study. Med J Aust 167 (1997) 72-75
3. Australian Institute of Health and Welfare (AIHW). Australian hospital statistics 2003-2004. AIHW Cat. No. 37. Canberra: AIHW; 2005.
4. Emberton M. The hallmarks of BPH progression and risk factors. Eur Urol Suppl 2 (2003) 2-7
5. Kirby R., and Christmas T. Benign prostatic hyperplasia (1993), Gower Medical Publishing, London
6. Giovannucci E., Rimm E., Chute C., Kawachi I., Colditz G., Stampfer M., et al. Obesity and benign prostatic hyperplasia. Am J Epidemiol 140 (1994) 989-1002
7. Sidney S. Vasectomy and the risk of prostate cancer and benign prostatic hypertrophy. J Urol 138 (1987) 795-797
8. Ning X., Shi J., Wu Z., Zheng L., and Wang H. A case-control study on the risk factors of benign prostatic hyperplasia in the suburb of Shenyang. Zhonghua Liu Xing Bing Xue Za Zhi 24 (2003) 276-280 [article in Chinese]
9. Platz E. Alcohol consumption, cigarette smoking and risk of benign prostatic hyperplasia. Am J Epidemiol 149 (1999) 106-115
10. Platz E. Physical activity and benign prostatic hyperplasia. Arch Intern Med 158 (1998) 2349-2356
11. Lacey J., Deng J., Dosemeci M., Gao Y., Mostofi F., Sesterhenn I., et al. Prostate cancer, benign prostatic hyperplasia and physical activity in Shanghai, China. Int J Epidemiol 30 (2001) 341-349
12. Mueller E., Latini J., Lux M., Kreder K., and Fitzgerald M. International prostate symptom score in young asymptomatic American men. BJU Int 95 (2004) 554-556
13. Habib F. The prostate: new concepts and developments (2004), Taylor and Francis, London
14. Kirby R., McConnell J., Fitzgerald J., Roehrbor C., and Boyle P. Textbook of benign prostatic hyperplasia (1996), Isis Medical Media, Oxford, UK
15. van Haarst E., Heldeweg E., Newling D., and Schlatmann T. A cross-sectional study of the international prostate symptom scores related to age and gender in Dutch adults reporting no voiding complaints. Eur Urol Suppl 47 (2004) 334-339
16. Hoffmann R., and Happle R. Current understanding of androgenetic alopecia. Part I: etiopathogenesis. Eur J Dermatol 10 (2000) 319-327
17. Denmark-Wahnefried W., Schildkraut J.M., Thompson D., Lesko S.M., McIntyre L., Schwingl P., et al. Early onset baldness and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 9 (2000) 325-328
18. Weisell R. Body mass index as an indicator of obesity. Asia Pac J Clin Nutr 11 Suppl (2002) S681-S684
19. Hodge A., Patterson A., Brown W., Ireland P., and Giles G. The Anti Cancer Council of Victoria FFQ: relative validity of nutrient intakes compared with weighed food records in young to middle-aged women in a study of iron supplementation. Aust N Z J Public Health 24 (2000) 576-583
20. Bairati I., Larouche R., Meyer F., Moore L., and Fradet Y. Lifetime occupational physical activity and incidental prostate cancer. Cancer Causes Control 11 (2000) 759-764
21. US Department of Labor. Dictionary of occupational titles. Washington, DC: US Government Printing Office; 1991.
22. Coogan P., and Aschengrau A. Occupational physical activity and breast cancer risk in the upper Cape Cod cancer incidence study. Am J Ind Med 36 (1999) 279-285
23. Kriska A., Sandler R., Cauley J., LaPorte R., Hom D., and Pambianco G. The assessment of historical physical activity and its relation to adult bone parameters. Am J Epidemiol 127 (1988) 1053-1063
24. Ainsworth B., Haskell W., Whitt M., Irwin M., Swartz A., Strath S., et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 3 9 Supplement (2000) S498-S516
25. Dupont W. Statistical modelling for biomedical researches (2002), Cambridge University Press, Cambridge
26. Watson V., Ryan M., Brown C.T., Barnett G., Ellis B.W., and Emberton M. Eliciting preferences for drug treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia. J Urol 172 (2004) 2321-2325
27. Crispo A., Talamini R., Gallus S., Negri E., Gallo A., Bosetti C., et al. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia. Urology 64 (2004) 717-722
28. Holman C., Wisniewski Z., Semmens J., Rouse I., and Bass A. Mortality and prostate cancer risk in 19 598 men after surgery for benign prostatic hyperplasia. BJU Int 84 (1999) 37-42
29. Australian Institute of Health and Welfare (AIHW). Morbidity of Vietnam veterans: a study of the health of Australia's Vietnam veteran community, vol. 3. Validation study. Canberra: AIHW; 1999.
30. Leavy J., Ambrosini G., and Fritschi L. Vietnam military service history and prostate cancer. BMC Public Health 6 (2006) 75
31. Chen W., Yang C.C., Chen G.Y., Wu M.C., Sheu H.M., and Tzai T.S. Patients with a large prostate show a higher prevalence of androgenetic alopecia. Arch Dermatol Res 296 (2004) 245-249
32. Oh B.R., Kim S.J., Moon J.D., Kim H.N., Kwon D.D., Won Y.H., et al. Association of benign prostatic hyperplasia with male pattern baldness. Urology 51 (1998) 744-748
33. Meigs J., Mohr B., Barry M., Collins M., and McKinlay J. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 54 (2001) 935-944
34. Nie Y., Guo X.K., Gao W.Y., Zhang Y., Li W.L., Cheng Q.X., et al. A survey of the long-term incidence rate of benign prostate hyperplasia after vasectomy. Zhonghua Yi Xue Za Zhi 83 (2003) 1303-1305 [article in Chinese]
35. Jakobsen H., Torp-Pedersen S., Juul N., and Hald T. The long-term influence of vasectomy on prostatic volume and morphology in man. Prostate 13 (1988) 57-67